Edit Csada

498 total citations
9 papers, 380 citations indexed

About

Edit Csada is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Edit Csada has authored 9 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 1 paper in Surgery. Recurrent topics in Edit Csada's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Edit Csada is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Edit Csada collaborates with scholars based in Hungary, United States and United Kingdom. Edit Csada's co-authors include Jaromı́r Roubec, Diane Prager, John V. Heymach, Roy S. Herbst, Bruce E. Johnson, Jeannie Hou, Miloš Pešek, I. Bodrogi, Sarah J. Kennedy and Shirish M. Gadgeel and has published in prestigious journals such as Journal of Clinical Oncology, Lung Cancer and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.

In The Last Decade

Edit Csada

9 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edit Csada Hungary 7 280 249 153 53 33 9 380
Eisuke Kurihara Japan 8 113 0.4× 148 0.6× 110 0.7× 48 0.9× 38 1.2× 12 271
Laura Emerson United States 5 285 1.0× 246 1.0× 89 0.6× 76 1.4× 12 0.4× 5 354
Graham Cohen South Africa 7 157 0.6× 205 0.8× 103 0.7× 43 0.8× 21 0.6× 18 316
Dongjun Shin United States 5 307 1.1× 375 1.5× 85 0.6× 26 0.5× 19 0.6× 8 448
Elisa Sottotetti Italy 11 106 0.4× 181 0.7× 101 0.7× 94 1.8× 11 0.3× 21 285
B.C. Cho South Korea 8 232 0.8× 204 0.8× 90 0.6× 47 0.9× 15 0.5× 33 280
David Ross Camidge United States 7 267 1.0× 216 0.9× 120 0.8× 51 1.0× 7 0.2× 16 337
Igor Odintsov United States 9 146 0.5× 123 0.5× 94 0.6× 52 1.0× 8 0.2× 24 235
Adel Zaatar Australia 5 376 1.3× 328 1.3× 126 0.8× 105 2.0× 8 0.2× 9 476
B. Escudier France 9 221 0.8× 94 0.4× 189 1.2× 120 2.3× 14 0.4× 41 327

Countries citing papers authored by Edit Csada

Since Specialization
Citations

This map shows the geographic impact of Edit Csada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edit Csada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edit Csada more than expected).

Fields of papers citing papers by Edit Csada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edit Csada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edit Csada. The network helps show where Edit Csada may publish in the future.

Co-authorship network of co-authors of Edit Csada

This figure shows the co-authorship network connecting the top 25 collaborators of Edit Csada. A scholar is included among the top collaborators of Edit Csada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edit Csada. Edit Csada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Zombori, Tamás, Tibor Nyári, László Tiszlavicz, et al.. (2018). The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis—a retrospective study on digitalized slides. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(6). 949–958. 16 indexed citations
3.
4.
Csada, Edit, et al.. (2018). A műtétileg kezelt tüdőrák klinikopatológiai jellemzőinek változása az ezredfordulónkon = Changes in the clinicopathological features of surgically treated lung cancer around the millennium. 1 indexed citations
5.
Radács, Marianna, Edit Csada, Sándor Pintér, et al.. (2013). Pulmonary epithelioid haemangioendothelioma studies in vitro and in vivo: new diagnostic and treatment methods.. PubMed. 27(2). 221–5. 6 indexed citations
6.
Heymach, John V., Bruce E. Johnson, Diane Prager, et al.. (2007). Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 25(27). 4270–4277. 232 indexed citations
7.
Heymach, John V., Bruce E. Johnson, Diane Prager, et al.. (2006). A phase II trial of ZD6474 plus docetaxel in patients with previously treated NSCLC: Follow-up results. Journal of Clinical Oncology. 24(18_suppl). 7016–7016. 53 indexed citations
8.
Herbst, Regina, Barry C. Johnson, Jacqui Rowbottom, et al.. (2005). O-100 ZD6474 plus docetaxel in patients with previously treatedNSCLC: Results of a randomized, placebo-controlled Phase II trial. Lung Cancer. 49. S35–S36. 22 indexed citations
9.
Heymach, John V., B. E. Johnson, Jacqui Rowbottom, et al.. (2005). A randomized, placebo-controlled phase II trial of ZD6474 plus docetaxel, in patients with NSCLC. Journal of Clinical Oncology. 23(16_suppl). 3023–3023. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eisuke Kurihara Breakdown of academic impact, for papers by Laura Emerson Breakdown of academic impact, for papers by Graham Cohen Breakdown of academic impact, for papers by Dongjun Shin Breakdown of academic impact, for papers by Elisa Sottotetti Breakdown of academic impact, for papers by B.C. Cho Breakdown of academic impact, for papers by David Ross Camidge Breakdown of academic impact, for papers by Igor Odintsov Breakdown of academic impact, for papers by Adel Zaatar Breakdown of academic impact, for papers by B. Escudier
Rankless by CCL
2026